Latest Close
₹4,580.00
-0.97%
Connecting…
Day Range
-
Full OHLC pending
Volume
-
Full session data pending
50 DMA
₹4,919.40
200 DMA
₹4,444.29
1 year gain / loss
+₹977.60(+27.14%)
₹3,602.40 → ₹4,580.00· 2025-10-30 to 2026-10-30
Charting by TradingView
This stock does not satisfy the default swing-support rules at the selected chart endpoint. Its price, volume and moving averages remain available for manual research.
Snapshot 2026-11-01 · Financial period Sep 2026 · Consolidated figures where available
Torrent Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. The Company is focused on various therapeutic segments, such as cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), vitamins minerals nutrients (VMN), anti-diabetes (AD), pain management, gynecology, and dermatology. Its pediatric product brands include Tedibar, Atogla, Spoo and B4 Nappi. Its Anti-diabetic products include Gliclazide 80 mg, Tablets, Gliclazide 30 mg, Tablets, Glimepiride 1, 2, 3, 4 mg, Tablets, and others. Its dermatologic therapy products include Macrotor, Ahaglow S Facewash, Fungicide Lotion, Hairjoy 2%, New Dewsoft Cream, Lookbrite 20GMS, Cortaz NC, Dermanex, and others. Its manufacturing facilities are located in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim.
Market Cap
₹1,76,306.21 Cr
P/E
84.00×
Sector -38.72× · above
P/B
9.60×
Sector 4.11× · above
EV / EBITDA
33.60×
Sector 22.21× · above
ROE
11.42%
Sector 0.31%
ROCE
11.37%
Sector 6.48%
ROA
4.70%
Sector -17.12%
Cash Flow / Profit
1.41×
| Period | Revenue | Operating profit | Net profit |
|---|---|---|---|
| Sep 2026 | 4,969 +1.2% | 737 | 534 -5.7% |
| Jun 2026 | 4,909 +17.4% | 733 | 566 +55.5% |
| Mar 2026 | 4,180 +27.1% | 529 | 364 -42.7% |
| Dec 2025 | 3,290 | 814 | 635 |
Dividend
29 May 2026 · ₹9
Dividend
18 Feb 2026 · ₹29